Checkpoint Therapeutics Inc

Planning a spring break getaway? Remember to protect your skin by choosing the right sunscreen. The American Academy of Dermatology provides expert answers to frequently asked questions on selecting the most effective sunscreen, proper application timing and how to maximize sun protection. Learn more:?https://lnkd.in/eyNdjw9f

While navigating skin concerns can be intimidating, know that you are not alone. Whether you're seeking a second opinion or specialized care, finding the right dermatologist for your needs is important. The American Academy of Dermatology offers guidance on selecting the best provider for you:?https://lnkd.in/ezPHUSQ3

This Black History Month, Checkpoint Therapeutics wants to remind you that while individuals with darker skin tones have a lower risk of skin cancer, it can still occur. Regular skin self-exams and sun protection are essential for everyone, regardless of skin color. The American Cancer Society offers tips on protecting your skin year-round. Learn more:?https://lnkd.in/eh-geCeC

This World Cancer Day, Checkpoint Therapeutics encourages you to protect your skin and stay vigilant through regular self-skin exams and professional screenings to detect skin cancer—one of the most common types of cancer. Remember, prevention and detection save lives. Learn more about the warning signs to watch for today and every day:?https://lnkd.in/gSVpQqn

ICYMI: Medscape reporter Sharon Worcester highlighted the FDA approval of Checkpoint’s UNLOXCYT (cosibelimab-ipdl), and how it can benefit individuals with advanced cutaneous squamous cell carcinoma (cSCC) who are not suitable candidates for surgery or radiation therapy. Read the full article here:?https://lnkd.in/eqPepUPw

Did you know that snow acts like a mirror, doubling your UV exposure by bouncing the sun’s rays back at you? Whether you're skiing, snowboarding, or simply shoveling the driveway this winter season, Checkpoint reminds you to prioritize sun safety as part of your daily routine. Check out the The American Academy of Dermatology winter skin survival kit for tips on staying protected:?https://lnkd.in/eUAJ_aYp

Find detailed information about UNLOXCYT (cosibelimab-ipdl) on our new landing page! Visit?www.unloxcyt.com?to learn more.

Thank you to Endpoints reporter Lei Lei Wu for highlighting our recent FDA approval and how this news marks our first marketing approval, transitioning Checkpoint into a commercial-stage entity. Read the full article here:?https://lnkd.in/e3zpwCMP

Happy Holidays! Checkpoint wishes you and your family a wonderful holiday season and a Happy New Year!

In case you missed it: Checkpoint Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted approval for UNLOXCYT (cosibelimab-ipdl), a treatment for adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are ineligible for curative surgery or radiation. Read below for insights from James Oliviero, CFA, President and Chief Executive Officer of Checkpoint, on this significant milestone.